Author :Sagitta Pharma

A Concrete Step for Biodiversity: Sagitta Pharma has installed beehives in the garden at its Fondettes site, in the heart of Touraine. This initiative is part of the company’s CSR strategy, with a simple goal: to integrate biodiversity into the site’s daily operations and raise awareness among staff about the role of pollinators.Bees and other pollinating insects play a vital role in the reproduction of both wild and cultivated plants. The French Office for Biodiversity notes that they contribute to the richness of ecosystems and that it is essential to better understand them in order to better preserve them. A local project, supported by a beekeeper To set up and monitor these beehives, Sagitta Pharma is working with a local beekeeper who handles the installation and maintenance of the colonies.This approach helps anchor the project in the local community and ensures tailored support. It also gives employees the opportunity to gain a more hands-on understanding of how a beehive works, the beekeeper’s craft, and practices that benefit pollinators. Four beehives and more than 120,000 little worker bees have now made their home on the Sagitta Pharma campus. A CSR Approach That Extends to the Workplace CSR is reflected not only in commitments but also in actions that are visible and understandable to everyone. The installation of beehives in Fondettes gives biodiversity a tangible presence on the site. It complements the initiatives already undertaken by Sagitta Pharma regarding environmental responsibility, quality of life at work, and local engagement.This initiative aligns with national priorities to support pollinators. The 2021–2026 National Pollinator Plan aims, in particular, to restore their habitats, improve their food sources, and strengthen efforts to protect them. Taking Action at Our Level Hosting beehives alone does not solve biodiversity challenges. But it is a concrete and genuinely useful action on several levels. In Fondettes, this project brings Sagitta Pharma’s CSR initiative to life in a simple way while collaborating with a local partner. It is a way to take action at our own level, with commitment and consistency. Sources

Since 2025, Sagitta Pharma has been partnering with PharmaGreen to reduce waste and repurpose damaged healthcare products, giving them a new use in the spirit of solidarity.This collaboration, which is particularly close to our hearts, is fully aligned with our CSR approach. It addresses a concrete goal: to prevent the destruction of products that are still usable, encourage reuse, and support organizations active on the ground. Following an initial six-month review, we are actively continuing this collaborative initiative with the results from the first quarter of 2026. An Act of Solidarity In the first quarter of 2026, 1,892 health products were saved from destruction and redistributed to two partner organizations: These donations represent nearly 280 kilograms of repurposed products. They give a second life to products that can no longer be sold but can still be useful in a spirit of solidarity and responsibility.  These redistributions give unsellable but still useful products a second life within a framework of solidarity and responsibility. An eco-friendly initiative Over the same period, the program prevented the emission of 160 kg of CO₂, equivalent to a round-trip from Paris to Bordeaux in a gasoline-powered car. This result confirms the value of a reuse approach in the pharmaceutical and parapharmaceutical sectors. By prioritizing reuse over disposal, Sagitta Pharma helps reduce the environmental footprint of its operations. A Long-Term CSR Commitment Following a very encouraging initial assessment in 2025, the start of this year confirms the ongoing partnership with PharmaGreen. For Sagitta Pharma, this initiative exemplifies a concrete, measurable, and collective approach to corporate social responsibility (CSR). It reinforces our commitment to a more responsible, more socially conscious, and more resource-conscious pharmaceutical industry. This Q1 2026 report thus marks a new milestone in an initiative we intend to pursue over the long term.

Réduire l’empreinte carbone liée aux déplacements professionnels La réduction de l’empreinte carbone issue des déplacements professionnels constitue aujourd’hui un enjeu majeur pour les entreprises engagées dans la transition écologique.Chez Sagitta Pharma, la mobilité représente une part significative des émissions de gaz à effet de serre. Consciente de cet impact, l’entreprise a mis en place une série d’actions concrètes visant à réduire durablement son empreinte environnementale. Ces initiatives s’inscrivent pleinement dans une stratégie RSE (Responsabilité Sociétale des Entreprises) ambitieuse, intégrée à la culture et aux valeurs de Sagitta Pharma. 👉 Découvrez notre politique RSE : Une flotte de véhicules électriques pour accompagner la transition Dans le cadre de son plan de réduction de l’impact carbone, Sagitta Pharma a déployé il y a quelques années déjà une flotte de véhicules hybrides et électriques pour les déplacements professionnels.Cette initiative favorise une mobilité plus responsable, tout en améliorant le confort et la sécurité des collaborateurs.Pour accompagner cette évolution, des bornes de recharge électrique ont été installées sur le parking de l’entreprise, facilitant la recharge sur site. Cette démarche encourage l’adoption de modes de déplacement à faible émission de CO₂, en cohérence avec les objectifs de transition énergétique fixés au niveau national. Une contribution carbone certifiée : 42 tonnes de CO₂ compensées Au-delà de la réduction directe des émissions, Sagitta Pharma agit pour une neutralité carbone mesurable et vérifiable.L’entreprise a obtenu une certification WeNow, attestant d’une contribution carbone de 42 tonnes de CO₂ compensées pour l’année 2025. Voir notre certificat contribution carbone 2025 : Cette certification garantit le financement de projets environnementaux certifiés à impact réel, favorisant la lutte contre le changement climatique à l’échelle internationale et locale. Soutien à un projet d’hydroélectricité certifié par l’ONU Parmi les projets soutenus figure Small Hydro – ID 1280, un projet d’hydroélectricité à petite échelle certifié par l’Organisation des Nations Unies. Ce type de projet repose sur la production d’électricité renouvelable à partir d’installations hydrauliques de faible puissance. Il contribue à : La certification ONU garantit que le projet respecte des méthodologies strictes en matière de réduction d’émissions et de suivi des impacts. Contribution à la reforestation en forêt communale française La contribution carbone de Sagitta Pharma inclut également le financement de la plantation de 11 arbres en forêt communale française, au sein de forêts gérées par l’Office National des Forêts au cœur des montagnes de l’Ain. Ces actions participent : Une démarche RSE intégrée à notre marque employeur Au-delà de l’impact environnemental, ces initiatives s’inscrivent dans une vision plus large de la responsabilité de l’entreprise en tant qu’employeur. La mise en œuvre d’actions concrètes en faveur de la mobilité durable contribue à créer un cadre de travail en phase avec les enjeux environnementaux actuels et les attentes sociétales. Agir de manière mesurable et vérifiable La démarche environnementale de Sagitta Pharma repose sur des actions mesurables, certifiées et vérifiables, combinant : Cette approche vise à inscrire la transition environnementale dans une logique de progrès continu, fondée sur des engagements concrets. FAQ – Mobilité durable et engagement carbone 1. Qu’est-ce que la mobilité durable ?La mobilité durable désigne l’ensemble des pratiques et technologies visant à réduire l’impact environnemental des déplacements, notamment via les transports doux ou électriques. 2. Pourquoi Sagitta Pharma s’engage-t-elle dans la mobilité durable ?Parce que certains déplacements professionnels représentent une part importante des émissions de CO₂, et que Sagitta Pharma souhaite agir concrètement pour limiter son empreinte carbone. 3. Que représente la contribution carbone WeNow ?C’est une certification attestant que Sagitta Pharma compense une partie de ses émissions en finançant des projets écologiques reconnus. 4. Quels sont les bénéfices d’une flotte électrique ?Une flotte hybride et électrique réduit les émissions directes de CO₂ et confirme la responsabilité de l’entreprise. 5. Qu’est-ce qu’un projet d’hydroélectricité certifié par l’ONU ?Il s’agit d’un projet utilisant la force de l’eau pour produire de l’électricité renouvelable, validé selon des standards internationaux stricts. 6. En quoi la reforestation contribue-t-elle à la neutralité carbone ?Les arbres captent et stockent le CO₂ de l’atmosphère, compensant ainsi une partie des émissions humaines. Conclusion : Sagitta Pharma, un acteur engagé pour une mobilité durable À travers ses actions en faveur de la mobilité durable, de la réduction carbone, et de la compensation environnementale, Sagitta Pharma confirme son engagement envers un avenir plus responsable.L’entreprise démontre qu’il est possible de concilier performance économique, bien-être des collaborateurs, et respect de l’environnement, dans une logique d’amélioration continue.

After six months of collaboration, the Sagitta Pharma CSR partnership with PharmaGreen has produced its first concrete and measurable results, illustrating the laboratory's commitment to a more responsible pharmaceutical industry. The objective is clear: to reduce waste, limit our environmental impact, and strengthen solidarity, while complying with a strict regulatory framework. An initial assessment now allows us to measure the tangible results of this collaboration. See the article announcing the launch of the project: https://entreprise.sagittapharma.com/un-partenariat-porteur-de-sens-pour-une-sante-plus-responsable-avec-pharmagreen/ The goal: to enable the reuse of unsellable pharmaceutical products destined for destruction, while having a real social and environmental impact. This initial assessment allows us to evaluate the concrete results of this collaboration. Giving pharmaceutical products a second life Launched with a strong environmental and societal ambition, the partnership between Sagitta Pharma and PharmaGreen aims to give unsellable but still usable pharmaceutical products a second life by redirecting them to secure solidarity channels. This initiative is fully in line with Sagitta Pharma's CSR strategy and consistent with the current challenges facing the industry: A structured system In six successive collections, 5,293 essential products were saved from destruction and reused in a supervised and solidarity-based framework. These products, which would have been disposed of through conventional channels, have thus found a new social purpose. A direct social impact thanks to partner associations The products collected were redistributed via three major associations in France and internationally: Thanks to these redistributions, thousands of people in precarious situations, isolated or in emergency situations, were able to access essential products, helping to improve their daily lives. Reuse and the environment: a measurable impact Beyond the social issue, the reuse of products directly contributes to reducing Sagitta Pharma's environmental footprint. At the end of December, the first collections had prevented 445 kg of CO₂ emissions, according to the system's consolidated data.This impact corresponds in particular to: These indicators make the environmental impact of reuse tangible, in line with a logic of sobriety and the circular economy. A CSR approach integrated into Sagitta Pharma's business This partnership is fully in line with Sagitta Pharma's CSR strategy, which is based on three pillars: In line with this approach, Sagitta Pharma also allows its customers to access this reuse system, offering them a simple, structured solution that is adapted to the operational constraints of pharmacies. An approach now open to Sagitta Pharma customers Since early 2026, the Pharmagreen system has been available to Sagitta Pharma customers, allowing them to easily integrate this responsible approach into their professional practice, while benefiting from a secure regulatory framework. A dynamic set to continue This initial assessment confirms the relevance of this approach to environmental and social responsibility, integrated into the realities on the ground. In 2026, we intend to continue our partnership with PharmaGreen, with the ambition of further strengthening its impact in the service of a more responsible, committed, and supportive pharmaceutical industry.

At Sagitta Pharma, we are convinced that a company has a role to play far beyond its primary mission. As a wholesaler-distributor, Sagitta Pharma has the capacity to go beyond its distribution role. At a time when environmental and social issues are more than ever at the heart of our concerns, we have decided to take concrete action to contribute to a more sustainable, supportive and respectful model. To reinforce this approach, we have chosen to take concrete action: to give a second life to our unsold, damaged or near-expiry products, instead of destroying them. That's why we decided to work with PharmaGreen, a company specializing in the recycling of pharmaceutical products. Thanks to this partnership, these products are collected and redistributed to local associations. We saw this partnership as an obvious choice. This type of initiative unites us around shared values of solidarity, respect and commitment. It's also a source of pride for us to work for a company that makes a commitment and gives meaning to every action. Because our unsold products can change lives. At Sagitta Pharma, we believe it is possible to combine performance and responsibility. With PharmaGreen, we are taking a further step towards a more sustainable, supportive and humane pharmacy. Together, let's build the healthcare of tomorrow: more respectful of resources, closer to real needs, and more human.

At Sagitta Pharma, we are convinced that social responsibility is not limited to environmental commitments. While we often talk about sustainable development, reducing our carbon footprint or responsible consumption, it is just as essential - in our eyes - to focus on another fundamental axis: the well-being of the people who bring the company to life on a daily basis. Taking care of our teams: a commitment Our CSR approach fully integrates this human dimension. It is based on a certainty: a high-performance, sustainable company is first and foremost one that takes care of the health, balance and fulfillment of its employees. In our pharmaceutical business, where productivity is a daily concern, it can be easy to fall prey to fatigue, isolation, chronic stress and a sedentary lifestyle. These are all risk factors for physical and mental health, which can have an impact on team commitment and the quality of work. At Sagitta Pharma, we have chosen to act upstream. We have a self-service gym available to all Sagitta Pharma employees. What's more, every week we offer our employees sports sessions supervised by a professional coach. Several sessions are offered to suit everyone's schedule. This regular appointment is much more than a simple break in the schedule: it's designed as a lever for well-being and team cohesion. The benefits are manifold: these sessions create a collective moment where hierarchies disappear, where benevolence takes precedence over performance, and where we rediscover the simple pleasure of moving together. A corporate culture aligned with our values By implementing this type of initiative, we aim to build a working environment where every employee can flourish. This approach is part of a broader vision: that of a committed company, aware of its social role and ready to put people at the heart of its approach. It's not a question of following a trend, but of building a responsible business model in which quality of working life is a strategic lever - in the service of both employees and collective performance. To go further, together.